GENOMBIO (Booth No. T41) will participate in the "15th China (Taizhou) International Pharmaceutical Expo". You are welcome to visit the booth for negotiation.
With the theme of "Developing New Quality Productivity and Sharing a Healthy New Future", this event aims at the forefront of the development of domestic and foreign pharmaceutical and health industries from a new perspective, inviting more than 300 exhibitors to the exhibition, arranging more than 30 docking and exchange activities, and promoting the integrated development of the entire industry chain through a new immersive exhibition format, and further building the exhibition into the best stage for displaying innovative technological achievements, a bridge to enhance exchanges and cooperation, and a "weather vane" for observing the future development of the industry.
Highlights of the exhibition area at a glance
Matchmaking and exchange activities
1、Medical Expo Opening Ceremony
2、Shenzhen Big Health Industry Alliance Special: Shenzhen Big Health Industry Development Report Conference
Host: Tong Xie Yi
Co-organized by: Shenzhen Big Health Industry Alliance
3、Medical beauty special: Embrace supervision and tap into the new blue ocean of non-invasive medical beauty
Hosted by: Nanocrystal Biotechnology, Tongxieyi
4、Silver Economy Special Session: Longevity Medicine Based on Advanced Medical Care
Host: Tong Xieyi, China Geriatrics and Geriatric Medicine Aging Health Science Popularization Committee
Co-organized by: Hong Kong Longevity Medicine Center
5、CGT Special: The Path to CGT-CMC Director
Host: Tongxieyi CGT Club
6、Nuclear Medicine Special: China's New Drugs Go "Nuclear"
Host: Tongxieyi Nuclear Medicine Chain Alliance
7、Special Session on New Drug Thoughts: The Logic of Innovative Drugs in China and the United States
Host: Tong Xie Yi
8、Tianze M&A Special Session: Opportunities and Challenges of Biopharmaceutical M&A/BD
Hosted by: Tianze Capital, Tongxieyi
9、Exosomes special session: Exosomes industry technology trends口
Hosted by: Tong Xieyi
Co-organized by: Yinuo Micro-Pharmaceuticals
10、Pet Medicine Session: Pet Medicine Innovation and Global Market Development
Host: National Key Laboratory of New Drug Target Discovery and New Drug Creation for Major Diseases, Center for Advanced Scientific Translation of Pets, Tong Xieyi
11、Acne Special: Acne Treatment Medical Frontier
Organizer: Fengrui Pharmaceutical, Shengdou Xiaoyao
Co-organizer: Zhongchuangantang, Mingze Zhonghe
12、Synthetic Biology Session: "The trend is coming --- synthetic biology leads the new development of medical and health industry"
Host: Bio Island Industrial
Service Co-organizer: The 9th "Maker China" Biopharmaceutical SME Innovation and Entrepreneurship Competition Organizing Committee
13、AI Special Session: AI Technology Empowers the Medical and Health Industry
Host: Tongxieyang
14、Rongjie Biotech Special Session: Exchange on Consumer Medical Industry Chain会
Host: Rongjie Biotechnology
15、NewCo Special: NewCo Opportunities for Chinese New Drugs
Hosted by: Button Capital, Tongxieyi
16、ADC Special Session: Building an Innovation Ecosystem for Biopharmaceuticals
Host: Tong Xie Yi
17、Medical Beauty Special: Material Innovation and Transformation of Light Medical Beauty Industry
Hosted by: China Research Hospital Association Medical-Engineering Transformation and Health Industry Integration Committee, Tong Xieyi
Co-organized by: Jiutai Medical
Host: China Medical Tongue Circle
GENOM Biological
Zhejiang GENOM Life and Health Holding Group Co., Ltd. (GENOMBIO for short) was founded in February 2002. The group is headquartered at F12, Building E1, Zhejiang University Zijin Science and Technology Town, Xihu District, Hangzhou City, Zhejiang Province. The group holds 7 wholly-owned subsidiaries, including Zhejiang GENOM Saibaier Biotech, Zhejiang Xinuo Junkang Biotech, Hangzhou GENOM Biotechnology, Hangzhou GENOM Health Management, Shanghai GENOM Cell Biotech, Shanghai ORG Biotech, and GENOM Biotechnology (Anhui). It is a comprehensive national high-tech enterprise in China that integrates R&D, production, sales, and technical services in the field of biomedicine and health. Its business covers the entire health industry chain, including cell culture reagents, consumables, medical devices, organoids, cell storage, cell gene testing, and cell therapy drug development.
